News
Title : Hemodynamic effects of TX45 , a long-acting Fc-relaxin fusion, in Group 2 pulmonary hypertension patients. Session : Late-breaking science in heart failure, cardiomyopathies, pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback